Related Experiment Video
Updated: Jul 29, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
[Sentinel lymph node biopsy in breast cancer]
A Rody1, C Solbach, M Kaufmann
1Klinik für Gynäkologie und Geburtshilfe, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt/Main.
Summary
Sentinel node biopsy (SNB) accurately determines breast cancer axillary node status, reducing surgical morbidity. Proper technique and indications are crucial for accurate staging and effective adjuvant therapy.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Background:
- Breast cancer surgery has evolved to minimize radicality in both the breast and axilla.
- Sentinel node biopsy (SNB) is a key technique for assessing axillary lymph node status in breast cancer patients.
- SNB reduces the morbidity associated with traditional axillary lymph node dissection.
Purpose of the Study:
- To outline the essential requirements for performing SNB.
- To detail the appropriate indications for SNB in breast cancer management.
- To identify and discuss potential pitfalls that can affect SNB accuracy.
Main Methods:
- Review of current surgical practices and literature regarding sentinel node biopsy.
- Analysis of factors influencing the sensitivity and specificity of SNB.
- Discussion of controversial aspects and areas requiring further research.
Main Results:
- SNB is a reliable method for axillary staging when performed correctly.
- Incorrect indications or surgical inexperience can compromise SNB accuracy.
- Inaccurate staging due to SNB errors can lead to suboptimal adjuvant therapy decisions.
Conclusions:
- Sentinel node biopsy is a valuable tool in breast cancer surgery, but requires precise execution.
- Further clinical studies are needed to address controversies like micrometastasis prognostic value and SNB use in specific scenarios (e.g., post-neoadjuvant chemotherapy, DCIS).
